I'm a bit surprised that we're only looking at the results of targeted therapy in late-stage cancer. It seemed apparent to me from the name that targeted therap

I'm a bit surprised that we're only looking at the results of targeted therapy in late-stage cancer. It seemed apparent to me from the name that targeted therapies were supposed to be less toxic, so they could be used in patients who weren't effectively dead, i.e., in earlier-stage cancers. Late-stage malaria and tuberculosis have terrible survival rates, and those are diseases we're supposed to be good at treating.